The Obsolescence of Carryforward in the Delaware R&D Tax Credit Regime: An Analysis of Statutory Refundability
I. Executive Summary: The Definition of Unused Credit Carryforward in Delaware Tax Law
The carryforward of an unused tax credit is a statutory provision that allows a taxpayer to apply credit amounts exceeding the current year’s tax liability against tax obligations incurred in future years.1 In the context of the current Delaware Research and Development (R&D) Tax Credit, this traditional mechanism is functionally obsolete, as the state’s program is fully refundable, converting any unused portion into an immediate cash refund.3
Critical Legislative Finding: Refundability Over Carryforward
The fundamental nature of the Delaware R&D Tax Credit (governed by Del. Code Ann. tit. 30, §§ 2070-2075) underwent a critical transition following legislative changes enacted in 2017. Specifically, for tax years beginning after December 31, 2016, the R&D credit became fully refundable.4 This change holds profound implications for tax planning and liquidity for businesses engaged in qualified research activities (QREs) within the state.
Because the credit is fully refundable, any calculated credit amount that exceeds the taxpayer’s Delaware corporate income tax liability is not deferred but is instead paid out as a direct cash refund by the Delaware Division of Revenue.6 This feature serves as a legislative substitute for the traditional carryforward mechanism. The primary purpose of a carryforward provision—to preserve the value of an unused credit for future utilization—is instantly satisfied by issuing cash in the current tax year. Consequently, the necessity for a complex, multi-decade tracking system, similar to the federal structure, is eliminated for credits generated under the post-2017 Delaware R&D statute, maximizing immediate economic stimulus and minimizing administrative complexity for taxpayers.
II. Foundational Tax Concepts: The Mechanics and Utility of Credit Carryforward
A clear understanding of the general mechanics of credit carryforward is essential to appreciate the significance of Delaware’s deviation from the standard tax incentive model.
Carryforward of Unused Credit: A Comprehensive Definition
An unused credit occurs when the total calculated credit amount for a given tax year exceeds the tax liability limitation imposed on the taxpayer.2 For example, the federal General Business Credit (GBC), which provides the structural benchmark for many state credits, generally allows the utilization of current year credits and credits carried forward from prior years against the tax liability limitation.1 If the total credit exceeds this limitation, the remaining unused credit may be preserved by the taxpayer for future application.
The federal system, guided by the Internal Revenue Code (IRC), stipulates that most unused general business credits may be carried back one year, and then carried forward for up to 20 years.1 This extensive period ensures that even companies with long development cycles or extended periods of non-profitability have the opportunity to utilize their incentives. The long carryforward period is intrinsically linked to the concept of a non-refundable credit, as it serves as the sole mechanism for retaining the credit’s value when the current year’s liability is insufficient to absorb it.2 If a credit were non-refundable and lacked a carryforward mechanism, the excess credit would be permanently lost.
Contrasting Refundable vs. Non-Refundable Credit Structures
Tax credits are generally classified into two categories, dictating how unused portions are treated:
- Non-Refundable: This type of credit can only be used to reduce the taxpayer’s liability down to zero. Any excess credit amount cannot be recovered in cash and must be carried forward to future tax years or, in some cases, carried back.7
- Refundable: This type of credit is first used to reduce the tax liability to zero. Crucially, the remaining excess credit is then processed and returned to the taxpayer as a cash payment.3 This structure completely bypasses the need for carryover tracking, providing immediate economic liquidity.
Historical Context of Delaware Carryforward Rules
Prior to the statutory amendments effective in 2017, the Delaware R&D credit adhered to a non-refundable structure. In this older regime, the amount of credit utilized was restricted, often limited to a percentage of the tax otherwise due (e.g., 50%).5 Any unused portion resulting from this limitation was required to be carried forward against future tax liabilities. Secondary resources referencing this historical structure indicate that unused amounts could be carried forward for up to 15 years.7 For established businesses, it remains essential to account for any unused R&D credits earned under this pre-2017 structure, as those legacy credits remain non-refundable and subject to the 15-year carryforward period, requiring careful tracking and chronological application against current liability.
The existence of varying carryforward periods cited in relation to Delaware tax law (15 years for historical R&D credits 7 versus 10 years for certain other credits like the Historic Preservation Tax Credit 8) underscores the necessity for taxpayers to reference the specific statutory language for each credit program, rather than relying on general administrative standards.
III. The Delaware R&D Tax Credit: Calculation and Qualification Requirements
The determination of the calculated R&D credit amount is the prerequisite step before the credit’s disposition (i.e., refund or carryforward) is addressed. The Delaware statute offers flexibility in calculation while maintaining clear qualification criteria.
Statutory Authority and Eligibility
The Delaware R&D Tax Credit is authorized under Del. Code Ann. tit. 30, § 2070, providing incentives for qualified research expenditures conducted within the state.3 The credit is accessible to various entity types, including corporations (C Corps and S Corps) and flow-through entities such as partnerships and Limited Liability Companies (LLCs), with credits passing through to owners in the latter case.3 A critical requirement for state eligibility is that the business must also be claiming or be eligible to claim the corresponding federal R&D tax credit (IRS Form 6765, Credit for Increasing Research Activities).7
Dual Calculation Methods: Annual Election
Taxpayers must make an annual, independent election between two distinct calculation methods, irrespective of the method used for the federal R&D credit.4
Method 1: Based on Excess Qualified Research Expenses (QREs)
This method calculates the credit based on the excess of the taxpayer’s total Delaware QREs for the taxable year over the taxpayer’s Delaware base amount.9
- Standard Rate: The credit is equal to 10% of the excess QREs over the base amount.3
- Small Business Rate: For taxpayers defined as a “small business” (those with average annual gross receipts not exceeding the statutory threshold of $20,000,000) 9, the rate is doubled to 20% of the excess QREs over the base amount.3
Method 2: Based on Apportioned Federal Alternative Simplified Credit (ASC)
This method ties the state credit directly to the federal credit calculation methodology, specifically the Alternative Simplified Credit (ASC) method under IRC $\S 41(c)(5)$.9
- Standard Rate: The credit is equal to 50% of Delaware’s apportioned share of the federal ASC.3
- Small Business Rate: For qualifying small businesses (as defined above), the credit percentage is 100% of Delaware’s apportioned share of the federal ASC.3
The structure allowing small businesses to claim 100% of the apportioned federal ASC, coupled with the credit’s full refundability, is recognized as a key element of Delaware’s aggressive incentive strategy. Since the ASC method is often administratively simpler for younger companies lacking the extensive historical data required by the traditional method, this pairing minimizes administrative hurdles and maximizes immediate financial benefit for cash-constrained startups operating in high-growth sectors.3
Requirements for Documentation and Filing
To claim the credit, taxpayers must complete Delaware Form 2070AC or 2071AC (Application for Research & Development Tax Credit) and attach it to their Delaware Division of Revenue income tax return (e.g., Form 700 for corporations).7 The application must be supported by a copy of the Federal Form 6765 and a detailed breakdown of the Delaware-based QREs and supporting calculations.7
The following table summarizes the crucial elements of the modern Delaware R&D credit:
Table Title: Delaware R&D Tax Credit Calculation Methods and Refundability Status (Post-2017)
| Calculation Component | Method 1 (Excess QREs) | Method 2 (Apportioned Federal ASC) |
| Standard Credit Rate | 10% of QREs over Base Amount | 50% of Apportioned Federal ASC |
| Small Business Rate ($\le\$20M$ Gross Receipts) | 20% of QREs over Base Amount | 100% of Apportioned Federal ASC |
| Credit Limitation (Utilization) | None; offsets 100% of liability | None; offsets 100% of liability |
| Unused Credit Disposition | Fully Refundable (Cash Payout) | Fully Refundable (Cash Payout) |
| Statutory Basis | Del. Code Ann. tit. 30, $\S 2070(a)(1)$ | Del. Code Ann. tit. 30, $\S 2070(a)(2)$ |
IV. Statutory Analysis: The Repeal of Carryforward via Full Refundability
The shift from a non-refundable, capped system to a fully refundable, uncapped system fundamentally redefined how unused R&D credits are handled in Delaware.
The Pre-2017 Non-Refundable Regime
Before the pivotal legislative changes, the Delaware R&D tax credit was subject to significant limitations that necessitated the use of carryforward provisions. Notably, the amount of the credit that could be used in any single year was limited to 50% of the tax otherwise due.5 This limitation often resulted in an unusable credit balance, even for profitable companies. The excess credit that could not be utilized due to the 50% cap was then required to be carried forward, typically for up to 15 years, to offset tax liability in future periods.7
Furthermore, the aggregate annual amount of credits awarded statewide was subject to a $5 million cap.5 If the total amount of approved R&D credits claimed by all firms exceeded this cap, the available credits were prorated among the approved companies.5 This risk of proration deterred large-scale R&D investments, as businesses could not rely on receiving the full calculated benefit, thus compounding the uncertainty already inherent in managing a non-refundable credit carryforward.
Legislative Amendment and Sunset of Carryforward
The key legislation impacting the R&D credit became effective for tax years beginning after December 31, 2016.5 The bill introduced two primary structural changes:
- Elimination of the Cap: The $5 million aggregate annual credit cap was removed.5 This change guaranteed that all approved companies would receive the full credit amount calculated based on their QREs, regardless of the claims filed by other firms.
- Introduction of Refundability: The credit was made fully refundable. The statutory modification explicitly states that where the credit exceeds the amount of tax otherwise due, “the taxpayer is entitled to receive the excess in the form of a tax refund”.5
These concurrent legislative changes eliminated the need for a carryforward mechanism for credits generated in 2017 and subsequent years. The necessity for the 15-year carryforward arose solely from the non-refundable and limited nature of the prior credit. By removing the 50% utilization cap and replacing the carryforward with an immediate cash payment for any excess credit, the state prioritized certainty and scalability for R&D investment.
The Status of Carryforward for Legacy Credits
For businesses with historical operations in Delaware, any R&D credits generated in tax years prior to the 2017 effective date must still be accounted for under the old rules. These non-refundable legacy credits are subject to the original utilization limits and must be carried forward for their prescribed period (up to 15 years) until they are utilized or expire.7
In applying credits to current liability, standard tax protocol suggests that the non-refundable carryforward credits should be utilized first to offset current year tax liability, before the current year’s refundable R&D credit is applied. This sequence ensures that the maximum potential amount of the current year’s refundable credit is preserved for conversion into a cash payout.
V. Delaware Division of Revenue Guidance and Administrative Procedure
The Delaware Division of Revenue (DDR) administers the R&D Tax Credit, and its guidance confirms the administrative process centers on issuing a refund rather than tracking a deferred credit asset.
Claiming the Credit and Refund Procedure
The process begins with the completion and submission of the specific application forms, such notably Form 2070AC/2071AC, which includes the computation schedules for Method A and Method B.4 This form must be completed and attached to the taxpayer’s Delaware income tax return (e.g., Form 700 for corporate filers) for each year the credit is claimed.10
Once the credit is approved by the DDR, the calculated amount is transferred to the appropriate line on the income tax return (Form 700). The form allows the credit to be applied against the liability. The Division of Revenue confirms that if the approved credit amount surpasses the taxes owed to Delaware, the State processes and issues a tax refund for the difference.6 This administrative step is the functional equivalent of the former carryforward, transforming a deferred tax asset into immediate cash liquidity. The DDR also provides direct contact information for taxpayers needing assistance, demonstrating the state’s commitment to facilitating the program.10
Contrast with Non-Refundable Credit Administration
The R&D credit’s full refundability contrasts sharply with the administrative handling of other tax incentives within Delaware. For instance, the statute governing the Historic Preservation Tax Credit explicitly mandates that any unused portion of that credit “shall not be refunded, but may be carried forward as a credit against subsequent years’ income or franchise tax liability for a period not exceeding 10 years”.8
This stark administrative difference confirms the unique and highly favorable status the Delaware legislature has afforded to R&D investment. The choice to grant an immediate cash refund for R&D credit excesses simplifies audit and compliance procedures compared to the alternative. Tracking a non-refundable carryforward for 15 or 20 years necessitates meticulous record-keeping across numerous tax years, subjecting those accrued balances to the audit risk of intervening years. By providing a closed transaction (a cash payment) in the year the expense is incurred, the complexity and long-term financial risk associated with carryforward accounting are significantly mitigated for the R&D company.
VI. Case Study: Maximizing Credit Utilization through Refundability
To fully illustrate the outcome of the current law, consider a scenario involving a high-growth startup, demonstrating how full refundability provides a superior financial outcome compared to the traditional carryforward structure.
Scenario Details: Small Business Utilizing Enhanced Rates
Startup R&D Corp is a nascent biotechnology company operating entirely within Delaware. In its current tax year (2024), the company has substantial R&D expenditures but is still pre-profitability, resulting in minimal current tax liability. The company qualifies as a “Small Business” because its average annual gross receipts are less than $20,000,000.9 Startup R&D Corp elects to use the more beneficial calculation method (Method 1), leveraging the enhanced 20% rate.
Financial Metrics and Credit Calculation (2024 Tax Year)
The following table details the calculation of the R&D credit earned:
Table Title: Startup R&D Corp – Calculation of Delaware R&D Credit Earned (2024)
| Financial Metric | Amount ($) | Calculation Basis |
| Total Delaware QREs | 1,500,000 | Qualifying Research Expenses |
| Delaware Base Amount (DBA) | 800,000 | Calculated statutory base 3 |
| Excess QREs (QREs – DBA) | 700,000 | Amount subject to credit |
| Small Business Credit Rate | 20% | Enhanced rate for $\le\$20M$ gross receipts 9 |
| Total R&D Tax Credit Earned | 140,000 | 20% of $700,000 |
Credit Application and Disposition
Startup R&D Corp determined its Delaware Corporate Income Tax Liability for 2024 to be $40,000.
The total credit earned is $140,000. This credit is first used to offset the full $40,000 liability, reducing the company’s tax owed to $0.
- Unused Credit Remaining: $\$140,000 – \$40,000 = \$100,000$.
Under the current fully refundable regime, Startup R&D Corp does not record a $100,000 carryforward balance. Instead, the Division of Revenue processes and issues a cash refund of $100,000.6
The immediate realization of the $100,000 credit provides 100% utilization in the current year, providing superior non-dilutive working capital for the R&D company.
Table Title: Disposition of Unused Delaware R&D Credit (Current Fully Refundable Law)
| Metric | Amount ($) | Disposition under Refundable Law (Post-2017) | Disposition under Historical Carryforward Law (Pre-2017) |
| Total Credit Earned | 140,000 | Offset current tax liability | Offset current tax liability (limited by 50% cap) |
| Current Tax Liability | 40,000 | Reduced to $0 | Reduced to $0 |
| Unused Excess Credit | 100,000 | Issued as a Cash Refund 6 | Carried Forward for 15 Years 7 |
| Immediate Financial Benefit | $100,000 Cash Inflow | $0 (Deferred Tax Asset) |
VII. Strategic Financial Implications for Delaware Businesses
The shift in Delaware tax policy from carryforward to full refundability holds significant strategic implications for financial officers managing R&D capital and liquidity.
Enhanced Liquidity and Non-Dilutive Funding
For high-growth, early-stage businesses, which often operate at a loss during periods of intensive R&D investment, the ability to convert qualified expenditures directly into cash refunds provides a crucial source of non-dilutive working capital.3 This mechanism acts as a direct financial subsidy from the state, accelerating the pace of research and development faster than deferred tax assets (carryforwards), which are only realized when the company becomes profitable enough to utilize them. This strategic provision strengthens Delaware’s position as a desirable location for capital-intensive sectors like biotechnology and manufacturing.3
Simplified Tax Forecasting and Risk Reduction
The elimination of the carryforward mechanism simplifies multi-year tax planning immensely. Financial teams no longer need to forecast future taxable income with high certainty to model the utilization of carryforward credits, nor do they need to manage the expiration risk associated with the 15-year carryforward limit.7
By realizing the full value of the credit in the year the expense is incurred, the uncertainty linked to predicting potential future income tax rate changes or liability thresholds is removed. This operational simplicity and increased predictability of cash flow allow CFOs to allocate capital with greater confidence.
Compliance and Maintenance of Legacy Records
While the modern system simplifies filing for newly generated credits, corporations with a long history in the state must maintain strict compliance regarding legacy R&D credits. Any unused credits earned prior to the 2017 transition remain non-refundable and are subject to the prior 15-year carryforward rule.7 Accurate tracking and chronological utilization of these older, non-refundable assets is mandatory to prevent their expiration. These records must be clearly segregated from the newly earned, refundable credits to ensure compliance during any Division of Revenue audit.
VIII. Conclusion: Delaware’s Competitive Tax Advantage
The concept of “Carryforward of Unused Credit” for the Delaware R&D Tax Credit is, for most current taxpayers, a historical mechanism. The legislative decision, effective for tax years beginning after 2016, to mandate full refundability replaced the need for long-term carryforward, offering an immediate, superior cash benefit.
This policy shift, coupled with the elimination of the $5 million annual credit cap 5, positions Delaware’s R&D tax regime as highly attractive nationally. It offers unparalleled financial certainty and operational liquidity, particularly for early-stage and loss-generating companies, reinforcing the state’s dedication to fostering significant investment in qualified research and economic development. The state’s focus has moved decisively from deferring tax benefit (carryforward) to providing immediate, non-dilutive capital (refund).
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










